The above results strongly indicate that KIAA1522 is required for both the tumorigenesis and resistance to cisplatin in lung adenocarcinoma, these facts coincide with the clinical relevance of KIAA1522 in lung adenocarcinoma patients. This evidence concerns the gene NHSL3 and lung adenocarcinoma.